Skip to content

Carbetocin vs Prostadin in patients- Best drug for postpartum bleeding in cesarean deliveries.

Effectiveness and safety of Carbetocin vs Prostadin in patients with high risk of postpartum hemorrhage undergoing caesarean section - A Randomised control trial. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072930
Enrollment
59
Registered
2024-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Injection Carbetocin: 100mcg Carbetocin IV given over 1 minute immediately after delivery. Intervention2: Prostadin: Effectiveness and safety of Carbetocin vs Prostadin in patients with

Sponsors

Dr Rangarajan memorial hospital/ Sundaram Medical Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Prolonged labour Multiple pregnancies Obesity Anemia Macrosomia

Exclusion criteria

Exclusion criteria: Normal delivery Hypersensitivity to drugs Bronchial asthma

Design outcomes

Primary

MeasureTime frame
Need for additional uterotonics and blood transfusionTimepoint: 24 hours at baseline

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDR VISHRUTHA SRI S

Dr rangarajan memorial hospital; Sundaram Medical Foundation

druma@smfhospital.org9840370004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026